|
BIRC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.839300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.570300E-02 |
| Normal-vs-Stage2 |
1.78254999999572E-05 |
| Normal-vs-Stage3 |
3.543400E-03 |
| Normal-vs-Stage4 |
1.845120E-04 |
| Stage1-vs-Stage2 |
3.957500E-04 |
| Stage1-vs-Stage3 |
3.918200E-02 |
| Stage1-vs-Stage4 |
3.340400E-03 |
| Stage2-vs-Stage3 |
5.863500E-02 |
| Stage2-vs-Stage4 |
2.987200E-01 |
| Stage3-vs-Stage4 |
3.749600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.024300E-02 |
| Normal-vs-AfricanAmerican |
2.975000E-01 |
| Normal-vs-Asian |
2.164600E-01 |
| Caucasian-vs-AfricanAmerican |
5.418600E-01 |
| Caucasian-vs-Asian |
4.554000E-01 |
| AfricanAmerican-vs-Asian |
9.669000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.317940E-03 |
| Normal-vs-Female |
2.649800E-02 |
| Male-vs-Female |
6.582200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.046000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.359100E-03 |
| Normal-vs-Age(61-80Yrs) |
4.18089999998372E-06 |
| Normal-vs-Age(81-100Yrs) |
5.297500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.539100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.90719999998623E-06 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.674030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.612200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.089200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.554200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.498400E-01 |
| Classical-VS-Follicular |
3.9806999918568E-09 |
| Classical-VS-Other |
5.791000E-01 |
| Classical-VS-Normal |
2.014800E-01 |
| Tall-VS-Follicular |
2.995600E-03 |
| Tall-VS-Other |
7.649600E-01 |
| Tall-VS-Normal |
1.828610E-01 |
| Follicular-VS-Other |
1.952030E-01 |
| Follicular-VS-Normal |
2.78000000020207E-07 |
| Other-VS-Normal |
2.877600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.042200E-04 |
| Normal-vs-N1 |
1.381540E-02 |
| N0-vs-N1 |
5.180400E-01 |
|
|
